Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,564,500
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
46,455,501
-
Shares change
-
+2,842,351
-
Total reported value, excl. options
-
$1,707,224,921
-
Value change
-
+$103,228,229
-
Put/Call ratio
-
88.25%
-
Number of buys
-
79
-
Number of sells
-
-37
-
Price
-
$36.75
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q2 2018
147 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q2 2018.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46,455,501 shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (6,254,632 shares), FMR LLC (6,134,427 shares), Redmile Group, LLC (4,126,617 shares), BlackRock Inc. (3,364,604 shares), BRIDGER MANAGEMENT, LLC (2,459,253 shares), VANGUARD GROUP INC (2,381,354 shares), STATE STREET CORP (2,100,488 shares), MORGAN STANLEY (2,041,951 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,712,600 shares), and Camber Capital Management LP (1,620,000 shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.